Decision for a diagnostic clinical performance trial in the new region (sensitivity).

Table 4: Decision for a diagnostic clinical performance trial in the new region (sensitivity).

Δ	$\frac{{\overset{⌢}{P}}_{n e w}}{\overset{⌢}{P}}$	ρ	Decision New Region	Proportion of Subjects for Bridging Study	Sample Size for Bridging Study
0	1.00	1.00	No Clinical Trial	.	.
0.01	0.95	0.89	No Clinical Trial	.	.
0.02	0.86	0.78	Bridging Study	0.50	78
0.03	0.72	0.67	Bridging Study	0.31
0.04	0.56	0.56	Bridging Study	0.20
0.05	0.38	0.44	New Clinical Trial	.	.
0.06	0.24	0.33	New Clinical Trial	.	.
0.07	0.13	0.22	New Clinical Trial	.	.
0.08	0.06	0.11	New Clinical Trial	.	.